Updated urinary incontinence guidelinesUpdate provides concise approach to the evaluation, management of urinary incontinence in adults. Inlyta for metastatic renal cell carcinomaDrug is the fourth kinase inhibitor to be approved for treatment of metastatic renal cell carcinoma in Canada. Cialis approved for benign prostatic hyperplasia Tadalafil, a phosphodiesterase type 5 inhibitor, was formerly indicated only for the treatment of ED in men. Cranberry confirmed as UTI fighter Up yours: Montreal urologist helping men check their prostate health Chemoradiotherapy superior in muscle-invasive bladder cancer Radiation alone is inferior, ‘remarkable’ study shows How to preserve the brain while treating the bladder Some drugs kinder than others to the memory-impaired Toviaz for overactive bladder New drug is for in patients with symptoms of urinary frequency, urgency, and/or urge incontinence. Probiotics an option for UTIs New IV iron for anemia of chronic kidney disease New product is indicated for the treatment of iron deficiency anemia in adults with chronic kidney disease. First Previous 11 12 13 14 15 Next Last